Literature DB >> 29305680

Silent somatotroph pituitary adenomas: an update.

Fabienne Langlois1,2,3, Randall Woltjer4, Justin S Cetas5,3, Maria Fleseriu6,7,8.   

Abstract

Silent growth hormone adenomas (SGHA) are a rare entity of non-functioning pituitary neuroendocrine tumors. Diagnosis is invariably made post-operatively of a tumor immunopositive for GH (and Pit-1 in selected cases) but without clinical acromegaly. Mainly young females are affected, and tumors are often uncovered by investigation for headaches or oligoamenorrhea. Integration of clinical, pathological and biochemical data is required for proper diagnosis. Beside normal IGF-1 levels, a third of SGHAs displays elevated GH levels and some will eventually progress to acromegaly. Almost two-thirds will be mixed GH-prolactin tumors and sparsely-granulated monohormonal GH tumors seems the more aggressive subtype. Recurrence and need for radiation is higher than other non-functioning tumors so close follow-up is warranted.

Entities:  

Keywords:  Neuroendocrine tumors; Non-functioning pituitary adenomas; Pituitary; Silent somatotroph; Somatotroph adenomas

Mesh:

Substances:

Year:  2018        PMID: 29305680     DOI: 10.1007/s11102-017-0858-y

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  63 in total

1.  Silent growth hormone secreting pituitary adenomas: IGF-1 is not sufficient to exclude growth hormone excess.

Authors:  S Kalavalapalli; H Reid; J Kane; H Buckler; P Trainer; A H Heald
Journal:  Ann Clin Biochem       Date:  2007-01       Impact factor: 2.057

2.  The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas.

Authors:  Hiroshi Nishioka; Naoko Inoshita; Ozgur Mete; Sylvia L Asa; Kyohei Hayashi; Akira Takeshita; Noriaki Fukuhara; Mitsuo Yamaguchi-Okada; Yasuhiro Takeuchi; Shozo Yamada
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

Review 3.  Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary.

Authors:  Luis V Syro; Fabio Rotondo; Carlos A Serna; Leon D Ortiz; Kalman Kovacs
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

4.  Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control study.

Authors:  Alessandra Fusco; Antonella Giampietro; Antonio Bianchi; Vincenzo Cimino; Francesca Lugli; Serena Piacentini; Margherita Lorusso; Anna Tofani; Germano Perotti; Libero Lauriola; Carmelo Anile; Giulio Maira; Alfredo Pontecorvi; Laura De Marinis
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

Review 5.  Estrogens and selective estrogen receptor modulators in acromegaly.

Authors:  Felipe H Duarte; Raquel S Jallad; Marcello D Bronstein
Journal:  Endocrine       Date:  2016-10-04       Impact factor: 3.633

Review 6.  Prolactin as an autocrine/paracrine growth factor in human cancer.

Authors:  Nira Ben-Jonathan; Karen Liby; Molly McFarland; Michael Zinger
Journal:  Trends Endocrinol Metab       Date:  2002-08       Impact factor: 12.015

Review 7.  Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry.

Authors:  Wolfgang Saeger; Dieter K Lüdecke; Michael Buchfelder; Rudolf Fahlbusch; Hans-Jürgen Quabbe; Stephan Petersenn
Journal:  Eur J Endocrinol       Date:  2007-02       Impact factor: 6.664

8.  Apparently silent somatotroph adenomas.

Authors:  P Pagesy; J Y Li; M Kujas; F Peillon; O Delalande; A Visot; P Derome
Journal:  Pathol Res Pract       Date:  1991-12       Impact factor: 3.250

9.  A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas.

Authors:  Shozo Yamada; Kenichi Ohyama; Manabu Taguchi; Akira Takeshita; Koji Morita; Koji Takano; Toshiaki Sano
Journal:  Neurosurgery       Date:  2007-09       Impact factor: 4.654

10.  Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation.

Authors:  Andrea G Lania; Stefano Ferrero; Rosario Pivonello; Giovanna Mantovani; Erika Peverelli; Antonella Di Sarno; Paolo Beck-Peccoz; Anna Spada; Annamaria Colao
Journal:  J Clin Endocrinol Metab       Date:  2009-11-04       Impact factor: 5.958

View more
  8 in total

1.  Predicting early post-operative remission in pituitary adenomas: evaluation of the modified knosp classification.

Authors:  Marie Buchy; Véronique Lapras; Muriel Rabilloud; Alexandre Vasiljevic; Françoise Borson-Chazot; Emmanuel Jouanneau; Gérald Raverot
Journal:  Pituitary       Date:  2019-10       Impact factor: 4.107

Review 2.  Aggressive nonfunctioning pituitary neuroendocrine tumors.

Authors:  Sérgio Portovedo; Leonardo Vieira Neto; Christina Maeda Takiya; Leandro Miranda-Alves; Paula Soares; Denise Pires de Carvalho
Journal:  Brain Tumor Pathol       Date:  2022-06-20       Impact factor: 3.154

3.  Silent Corticotroph and Somatotroph Double Pituitary Adenoma: A Case Report and Review of Literature.

Authors:  Isabella L Pecorari; Lakshmi Priyanka Mahali; Abigail Funari; Roger Fecher; Nisha Suda; Vijay Agarwal
Journal:  J Neurol Surg Rep       Date:  2022-05-27

4.  Quantitative proteomics revealed the molecular characteristics of distinct types of granulated somatotroph adenomas.

Authors:  Yifan Tang; Tao Xie; Silin Wu; Qiaoqiao Yang; Tengfei Liu; Chen Li; Shuang Liu; Zhiyong Shao; Xiaobiao Zhang
Journal:  Endocrine       Date:  2021-05-27       Impact factor: 3.633

Review 5.  Clinical and Pathological Aspects of Silent Pituitary Adenomas.

Authors:  Juliana Drummond; Federico Roncaroli; Ashley B Grossman; Márta Korbonits
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

6.  Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas.

Authors:  Nicholas A Tritos; Pouneh K Fazeli; Ann McCormack; Susana M Mallea-Gil; Maria M Pineyro; Mirjam Christ-Crain; Stefano Frara; Artak Labadzhyan; Adriana G Ioachimescu; Ilan Shimon; Yutaka Takahashi; Mark Gurnell; Maria Fleseriu
Journal:  Pituitary       Date:  2021-07-20       Impact factor: 4.107

Review 7.  Aggressive pituitary neuroendocrine tumors: current practices, controversies, and perspectives, on behalf of the EANS skull base section.

Authors:  Sam Ng; Mahmoud Messerer; Julien Engelhardt; Michaël Bruneau; Jan Frederick Cornelius; Luigi Maria Cavallo; Giulia Cossu; Sebastien Froelich; Torstein R Meling; Dimitrios Paraskevopoulos; Henry W S Schroeder; Marcos Tatagiba; Idoya Zazpe; Moncef Berhouma; Roy T Daniel; Edward R Laws; Engelbert Knosp; Michael Buchfelder; Henri Dufour; Stéphane Gaillard; Timothée Jacquesson; Emmanuel Jouanneau
Journal:  Acta Neurochir (Wien)       Date:  2021-08-08       Impact factor: 2.816

8.  Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease.

Authors:  Beata Rak; Maria Maksymowicz; Monika Pękul; Grzegorz Zieliński
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-31       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.